NasdaqGS - Nasdaq Real Time Price
USD
COMPASS Pathways plc (CMPS)
12.07
-0.21
(-1.71%)
As of 2:11:46 PM EDT. Market Open.
Trade CMPS on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutCOMPASS Pathways is advancing its COMP360 synthetic psilocybin program toward a planned rolling NDA submission in Q4 2026. Recent company announcements center on Phase III research, clinician education, and preparation for a potential 2027 launch, while valuation commentary highlights substantial upside alongside clinical, regulatory, and funding risks.
